VJHemOnc is committed to improving our service to you

ASH 2015 | How far are we from a cure for CLL?

VJHemOnc is committed to improving our service to you

Thomas Kipps

Thomas Kipps, MD from the University of California, San Diego, CA, discussed the current treatment landscape in chronic lymphocytic leukemia (CLL), considering the novel therapies being presented at the American Society of Hematology (ASH) 2015 Annual Meeting.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter